Evidence map›Paper›PMID 42626940›Full record

ArticleJournal of clinical microbiology2026

Hailin Zheng, Wenting Xie, Yinggai Song, Cunwei Cao, Meng Fu, Biling Dong, Xiaodong Wang, Xue Kong, Naicen Ge, Huan Mei and 9 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Hailin Zheng *Department of Medical Mycology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.ORCID 0000-0003-0247-1853
Wenting Xie *Department of Medical Mycology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.ORCID 0000-0002-2738-7589
Yinggai Song *Department of Dermatology, Peking University First Hospital, Beijing, China.ORCID 0000-0002-1644-6942
Cunwei Cao *Department of Dermatology, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.ORCID 0000-0002-6279-0322
Meng Fu *Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Biling Dong *Department of Dermatology, Wuhan No.1 Hospital, Wuhan, Hubei, China.ORCID 0000-0002-0264-6441
Xiaodong Wang *Department of Dermatology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Xue KongDepartment of Medical Mycology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.ORCID 0000-0003-3483-8322
Naicen GeDepartment of Medical Mycology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.
Huan MeiDepartment of Medical Mycology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.
Ruoyu LiDepartment of Dermatology, Peking University First Hospital, Beijing, China.
Kaisu PanDepartment of Dermatology, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Yanyang GuoDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Zhongsheng TongDepartment of Dermatology, Wuhan No.1 Hospital, Wuhan, Hubei, China.
Paride AblizDepartment of Dermatology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Xiaodong SheDepartment of Medical Mycology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.ORCID 0000-0002-8719-0462
Weida LiuDepartment of Medical Mycology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.ORCID 0000-0003-1936-3736
Guanzhao LiangDepartment of Medical Mycology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.ORCID 0000-0002-5330-8864
Xiaofang LiDepartment of Medical Mycology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.ORCID 0000-0002-5148-2922

Funding

CAMS Innovation Fund for Medical Sciences 2025-I2M-C&T-B-080National Key Research and Development Program of China 2022YFC2504804
6 · The paper itself

Abstract

Dermatophytosis is a highly prevalent superficial fungal infection, yet antifungal susceptibility testing results remain difficult to interpret because clinical breakpoints are unavailable, and epidemiological cutoff values (ECVs) are still limited for most dermatophyte-drug combinations. We conducted a multicenter study of 305 IMPORTANCE: Reliable interpretation of dermatophyte antifungal susceptibility testing remains limited because clinical breakpoints and epidemiological cutoff values (ECVs) are unavailable for most dermatophyte-drug combinations. This is particularly important for the

Indexed as

Antifungal AgentsArthrodermataceaeTineaTrichophytonChinaHumansMicrobial Sensitivity TestsAntifungal Agentsantifungal susceptibilityCLSI M38epidemiological cutoff valuesTrichophyton interdigitaleTrichophyton mentagrophytes

Identifiers

PMID42626940
PMCPMC13556232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.